ÂÜÀòÂÒÂ×

Anderson has more than 17 years of diversified finance experience in multiple markets, within which, 10 years are in healthcare, covering both early stage preclinical and clinical development as well as in later stage commercialization efforts. He is a US CMA charter holder.

Anderson was executive finance director of Wuxi Apptec, a ~75Bn $ market value CRDMO company with global coverage, leading the global FP&A & finance BP team with more than 50 finance professionals. He supported the group vice chairman and CFO in managing the entire corporate P&L of affiliates in China, US & EU. Prior to Wuxi Apptec, Anderson was a financial planning & analysis director of Gilead Science China where he assisted the China GM and China finance head in the establishment of their China finance infrastructure from scratch. He also supported China GM in the entire product commercialization lifecyle from the commercial plan to product launch with NRDL reimbursement.